Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.62 |
| ▸ | HTR6 | P50406 | 5/20 | 0.57 |
| ▸ | DRD3 | P35462 | 4/20 | 0.57 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.55 |
| ▸ | RORC | P51449 | 1/20 | 0.55 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.55 |
| ▸ | DRD2 | P14416 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 4/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.52 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27675260 | 0.83 | DRD3 (0.57) | MAPTHTR6DRD3HRH3RORC | |
| SCHEMBL28768935 | 0.79 | MAPT (0.63) | MAPTMEN1KMT2ATP53 | |
| SCHEMBL29683115 | 0.79 | MAPT (0.63) | MAPTMEN1KMT2ATP53 | |
| SCHEMBL397088 | 0.79 | MAPT (0.78) | MAPTHTR6DRD3MEN1KMT2A | |
| SCHEMBL2510105 | 0.78 | MCL1 (0.75) | MAPTMEN1KMT2ATP53AKR1C3 | |
| SCHEMBL2512100 | 0.78 | MAPT (0.69) | MAPTMEN1KMT2ATP53 | |
| SCHEMBL287912 | 0.77 | HPGD (0.53) | MEN1KMT2ATP53 | |
| SCHEMBL8357237 | 0.76 | MAPT (0.62) | MAPTMEN1KMT2ATP53 | |
| SCHEMBL10186983 | 0.75 | MEN1 (0.69) | MAPTHTR6DRD3HRH3RORC | |
| SCHEMBL2074679 | 0.75 | DRD3 (0.62) | MAPTHTR6DRD3HRH3RORC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101891680-B | Modulators of ATP-binding cassette transporters | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2014-10-29 | — | — | CN | disclosed |
| CN-103641765-A | Modulators of ATP-binding cassette transporters | VERTEX PHARMA | 2014-03-19 | — | — | CN | disclosed |
| CN-101935301-B | Modulators of ATP-binding cassette transporters | VERTEX PHARMA | 2013-10-16 | — | — | CN | disclosed |
| CN-103254177-A | Modulators of atp-binding cassette transporters | VERTEX PHARMA | 2013-08-21 | — | — | CN | disclosed |
| CN-102652128-A | 4-Oxo-1H-quinoline-3-carboxamides as modulators of ATP-binding cassette transporters | VERTEX PHARMA | 2012-08-29 | — | — | CN | disclosed |
| CN-102272128-A | Modulators of atp-binding cassette transporters | — | 2011-12-07 | — | — | CN | disclosed |
| CN-101006076-B | Modulators of ATP-binding cassette transporters | VERTEX PHARMA | 2010-09-29 | — | — | CN | disclosed |
| CN-101460489-A | Modulators of ATP-binding cassette transporters | VERTEX PHARMA (US) | 2009-06-17 | — | — | CN | disclosed |
| CN-101006076-A | Modulators of ATP-binding cassette transporters | VERTEX PHARMA (US) | 2007-07-25 | — | — | CN | disclosed |